Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Inetetamab |
Trade Name | |
Synonyms | Cipterbin |
Drug Descriptions |
Inetetamab is a monoclonal antibody targeting ERBB2 (HER2), which potentially inhibits tumor growth (PMID: 38685972). |
DrugClasses | HER2 (ERBB2) Antibody 76 |
CAS Registry Number | NA |
NCIT ID | C179282 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Inetetamab | Inetetamab | 0 | 0 |
Inetetamab + Paclitaxel + Sirolimus | Inetetamab Paclitaxel Sirolimus | 0 | 0 |
Inetetamab + Pyrotinib | Inetetamab Pyrotinib | 0 | 0 |
Inetetamab + Pyrotinib + Vinorelbine | Inetetamab Pyrotinib Vinorelbine | 0 | 0 |